|
“Some Thoughts on Models, Modeling, and AI” |
01/25/2023 - 8:00am to 9:00am EST |
|
“In Extremis: Treatment of Metastatic Breast Cancer with Visceral Crisis.” |
12/14/2023 - 8:30am to 9:00am EST |
|
“Identifying precursors of resident memory T cells in cancer” |
09/27/2023 - 8:00am to 9:00am EDT |
|
What Do You Want to Do? / Breast Cancer Brain Metastasis: From Forgotten to Focus |
07/12/2023 - 8:00am to 9:00am EDT |
|
Updates on Treatment Options for Relapsed Ewing Sarcoma / Lung metastases in pancreatic cancer: navigating a positive prognostic marker |
03/15/2023 - 8:00am to 9:00am EDT |
|
Understanding irAEs / Racial disparities in reporting of common germline variants by commercial tumor NGS assays |
05/10/2023 - 8:00am to 9:00am EDT |
|
Translational Research in Cancer Health Disparities – A Cells to Society Approach |
10/25/2023 - 8:00am to 9:00am EDT |
|
Translating the Genome in Gastroesophageal Cancer (and some views from the other side...) |
03/22/2023 - 8:00am to 9:00am EDT |
|
Toward Achieving Cancer Health Equity: Ancestry-related Oncogenic Mechanisms and Precision Medicine Interventions |
05/03/2023 - 8:00am to 9:00am EDT |
|
Timeline to testing: exploring barriers that delay tumor molecular profiling across the Duke Cancer Network/Enfortumab Vedotin and Pembrolizumab in Locally Advanced and Metastatic Urothelial Carcinoma |
11/29/2023 - 8:00am to 9:00am EST |
Facebook
Twitter
LinkedIn
Forward